105 related articles for article (PubMed ID: 21105206)
1. [The rheumatologists' conflict of interest and biological medicines].
Gøtzsche PC; Lundh A
Ugeskr Laeger; 2010 Nov; 172(45):3126; author reply 3126. PubMed ID: 21105206
[No Abstract] [Full Text] [Related]
2. [Biological first-choice preparations in Region H].
Graudal N; Jacobsen S; Baslund B; Jürgens G
Ugeskr Laeger; 2010 Nov; 172(45):3127. PubMed ID: 21105207
[No Abstract] [Full Text] [Related]
3. [Hasty dead certain conclusions about TNF inhibitors].
Lindberg M
Ugeskr Laeger; 2010 Nov; 172(45):3125; author reply 3125. PubMed ID: 21105205
[No Abstract] [Full Text] [Related]
4. Tumor necrosis factor inhibitors for rheumatoid arthritis.
Scott DL; Kingsley GH
N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
[No Abstract] [Full Text] [Related]
5. [Danish data document therapeutic effect differences of tumor necrosis factor inhibitors in patient with rheumatoid arthritis].
Hetland ML
Ugeskr Laeger; 2010 Jun; 172(26):2003; author reply 2003-4. PubMed ID: 20681045
[No Abstract] [Full Text] [Related]
6. [Pharmacotherapy of rheumatoid arthritis in the era of genetically engineered biological preparations].
Nasonov EL
Ter Arkh; 2007; 79(5):5-8. PubMed ID: 17672066
[No Abstract] [Full Text] [Related]
7. Rheumatoid arthritis.
Burchini G; Orsi C
N Engl J Med; 2004 Sep; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
[No Abstract] [Full Text] [Related]
8. [Biological agents for therapy of rheumatoid arthritis--overview].
Takeuchi T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409
[No Abstract] [Full Text] [Related]
9. [Review of the protective effects of tumor necrosis factor inhibitors in rheumatoid arthritis].
Finckh A; Gabay C; Guerne PA
Rev Med Suisse Romande; 2004 Sep; 124(9):547-50. PubMed ID: 15552748
[TBL] [Abstract][Full Text] [Related]
10. New drugs for rheumatoid arthritis.
Messori A; Santarlasci B; Vaiani M
N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
[No Abstract] [Full Text] [Related]
11. The 'alphabet' of rheumatoid arthritis treatment.
Capriotti T
Medsurg Nurs; 2004 Dec; 13(6):420-8. PubMed ID: 15714747
[No Abstract] [Full Text] [Related]
12. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
[No Abstract] [Full Text] [Related]
13. New drugs for rheumatoid arthritis.
Olsen NJ; Stein CM
N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
[No Abstract] [Full Text] [Related]
14. Anti-TNF-alpha therapies: they are all the same (aren't they?).
Mpofu S; Fatima F; Moots RJ
Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
[No Abstract] [Full Text] [Related]
15. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL; Silman AJ
J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
[No Abstract] [Full Text] [Related]
16. Biologic therapy for rheumatoid arthritis.
Klippel JH
N Engl J Med; 2000 Nov; 343(22):1640-1. PubMed ID: 11096174
[No Abstract] [Full Text] [Related]
17. [Biological agents targeting on pro-inflammatory cytokines].
Takeuchi T
Nihon Rinsho; 2005 Sep; 63(9):1601-6. PubMed ID: 16164218
[TBL] [Abstract][Full Text] [Related]
18. [TNF antagonists in therapy of rheumatoid arthritis].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
[No Abstract] [Full Text] [Related]
19. Nucleosome accumulation and reduction of C-reactive protein are associated with the generation of anti-nuclear antibodies in patients with rheumatoid arthritis treated with adalimumab, but not with etanercept.
Priori R; Alessandri C; Magrini L; Cassarà EA; Ceccarelli F; Modesti M; Croia C; Bombardieri M; Valesini G
Ann Rheum Dis; 2009 Sep; 68(9):1514-6. PubMed ID: 19674992
[No Abstract] [Full Text] [Related]
20. Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001).
Ledingham J; Deighton C;
Rheumatology (Oxford); 2005 Feb; 44(2):157-63. PubMed ID: 15637039
[No Abstract] [Full Text] [Related]
[Next] [New Search]